SUVRETTA CAPITAL MANAGEMENT, LLC purchased 4.6% of their position (42K shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $403.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/5/2024ACC: 0000899140-24-001318
10% Owner
Since Apr 2024
+42K
Net shares
Net buyer
$403.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
42K acquired
Non-Derivative Transactions2
Common stock, par value $0.0001 per share
Indirect
Shares
+37.19K
Price / share
$9.60
Trade value
$357.02K
% of position
0.5%
12/3/2024
7.92M→7.96M
Common stock, par value $0.0001 per share
Indirect
Shares
+4.81K
Price / share
$9.60
Trade value
$46.18K
% of position
0.5%
12/3/2024
950.31K→955.12K
Total
Net shares
+42K
Net value
$403.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001 per share Indirect | 12/3/2024 | P · Purchase | +37.19K | $9.60 | $357.02K | 0.5% | 7.92M | 7.96M |
| Common stock, par value $0.0001 per share Indirect | 12/3/2024 | P · Purchase | +4.81K | $9.60 | $46.18K | 0.5% | 950.31K | 955.12K |
| Total | +42K | $403.20K | ||||||
Derivative Transactions0
No derivative transactions reported